Compound 47 efficiently downregulated GPX4 protein expression, rose cellular ROS levels and inhibited at 15 mg/kg (single dose; application route is not given) tumor growth (4.5‐fold) in a murine xenograft model of HepG2 cells. Here, GPX4 is linked to neoplasm.